Ozge Altunbas Goktekin

Ozge Altunbas Goktekin has extensive experience in various roles within the pharmaceutical and consulting industries. Ozge is currently the Managing Director for Europe & Asia at PharmaJet, where they oversee operations in these regions. In addition to their role at PharmaJet, Ozge is also the Founder of Ozz Consulting, a consulting firm they established in 2020.

Prior to their current positions, Ozge held a significant role as the Managing Director at VSY Biotechnology from 2017 to 2019. Ozge was responsible for implementing business strategies that resulted in maximum growth and profits for the company. Under their leadership, VSY Biotechnology was recognized by Deloitte as the Best Managed Company in 2019. Before becoming the Managing Director, Ozge served as the Head of International Sales Marketing at VSY Biotechnology from 2013 to 2017. Ozge was instrumental in developing successful sales and marketing strategies to achieve the company's short and long-term goals.

Earlier in their career, Ozge held the position of Head of National Sales & Marketing at VSY Varlibaslar Sag. Yat. Ltd. Sti. from 2008 to 2013. Ozge was responsible for driving sales growth through the implementation of effective marketing strategies, analyzing market trends, and organizing promotional campaigns.

Ozge began their professional journey at VSY Varlibaslar Sağlık Yatırımları in 2001, where they worked as both an Import Specialist and an MT (Management Trainee). Ozge also served as a Sales Manager and Supply Chain Manager at VSY Varlibaslar Sag Yat Ltd Sti. from 2004 to 2008.

Overall, Ozge Altunbas Goktekin's work experience showcases their expertise in business strategy, sales and marketing, and international operations within the pharmaceutical industry.

Ozge Altunbas Goktekin completed a Bachelor's degree in Business Administration and Management, General from Istanbul University from 1994 to 1998. Ozge also attended Harvard Business School for short-term programs in Sustainable Business Strategy in 2019 and Business Analytics in 2020.